BOSTON – October 29, 2026 -- TransCode Therapeutics (Nasdaq: RNAZ) has opened a formal strategic process that could end in a sale or licensing of its oncology assets, a partnership or a business combination, with lead candidate TTX-MC138 now in Phase 2a development.

SALT LAKE CITY – October 27, 2026 -- Thorne converted 80% of its paper batch records to electronic batch records (EBR) in 2026 using MasterControl Manufacturing Excellence (Mx), earning the Manufacturing Excellence Award at MasterControl's 2026 Masters Summit. The October event named four winners of the Masters of Excellence Awards, which recognize MasterControl customers in quality management, manufacturing, asset excellence and innovation.